Company Performance - Myomo, Inc. reported a quarterly loss of $0.08 per share, which aligns with the Zacks Consensus Estimate, an improvement from a loss of $0.10 per share a year ago [1] - The company posted revenues of $9.83 million for the quarter ended March 2025, exceeding the Zacks Consensus Estimate by 6.29%, compared to revenues of $3.75 million in the same quarter last year [2] - Over the last four quarters, Myomo has surpassed consensus EPS estimates three times and topped consensus revenue estimates four times [2][3] Stock Outlook - Myomo shares have declined approximately 25.9% since the beginning of the year, contrasting with the S&P 500's decline of 4.7% [3] - The current consensus EPS estimate for the upcoming quarter is -$0.06 on revenues of $10.35 million, and for the current fiscal year, it is -$0.07 on revenues of $50.95 million [7] Industry Context - The Medical - Products industry, to which Myomo belongs, is currently ranked in the bottom 28% of over 250 Zacks industries, indicating potential challenges for stock performance [8] - Empirical research suggests a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Myomo's stock performance [5][6]

Core Viewpoint - Groupon reported quarterly earnings of $0.18 per share, significantly beating the Zacks Consensus Estimate of a loss of $0.20 per share, marking an earnings surprise of 190% [1] - The company generated revenues of $117.19 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 1.46%, although this represents a decline from $123.08 million year-over-year [2] Group 1: Earnings Performance - Groupon's earnings of $0.18 per share compare favorably to earnings of $0.06 per share a year ago, indicating growth [1] - The company has surpassed consensus EPS estimates two times over the last four quarters [2] Group 2: Revenue Insights - The reported revenue of $117.19 million exceeded the consensus estimate, but is lower than the previous year's revenue of $123.08 million [2] - Groupon has topped consensus revenue estimates three times in the last four quarters [2] Group 3: Stock Performance and Outlook - Groupon shares have increased by approximately 39.3% since the beginning of the year, contrasting with a -4.7% decline in the S&P 500 [3] - The company's future stock performance will largely depend on management's commentary during the earnings call [3][4] Group 4: Earnings Estimates and Industry Context - Current consensus EPS estimate for the upcoming quarter is -$0.12 on revenues of $119.22 million, and -$0.25 on revenues of $497.1 million for the current fiscal year [7] - The Internet - Commerce industry is currently ranked in the top 31% of Zacks industries, suggesting a favorable outlook compared to lower-ranked industries [8]

Helmerich & Payne (HP) came out with quarterly earnings of $0.02 per share, missing the Zacks Consensus Estimate of $0.65 per share. This compares to earnings of $0.86 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of -96.92%. A quarter ago, it was expected that this oil and gas well-drilling contractor would post earnings of $0.69 per share when it actually produced earnings of $0.71, delivering a surprise of 2.90%.Over the las ...

Company Performance - F&G Annuities & Life, Inc. reported quarterly earnings of $0.72 per share, missing the Zacks Consensus Estimate of $1.19 per share, and down from $0.86 per share a year ago, representing an earnings surprise of -39.50% [1] - The company posted revenues of $908 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 38.36%, compared to $1.57 billion in revenues a year ago [2] - Over the last four quarters, the company has surpassed consensus EPS estimates two times and topped consensus revenue estimates two times [2] Stock Performance - F&G Annuities & Life, Inc. shares have lost about 14.1% since the beginning of the year, while the S&P 500 has declined by -4.7% [3] - The current status of estimate revisions is unfavorable, leading to a Zacks Rank 4 (Sell) for the stock, indicating expected underperformance in the near future [6] Earnings Outlook - The current consensus EPS estimate for the coming quarter is $1.20 on revenues of $1.52 billion, and for the current fiscal year, it is $5.05 on revenues of $6.18 billion [7] - The sustainability of the stock's price movement will depend on management's commentary during the earnings call [3][4] Industry Context - The Insurance - Life Insurance industry is currently in the bottom 43% of over 250 Zacks industries, suggesting that the outlook for the industry can materially impact stock performance [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

This quarterly report represents an earnings surprise of 16.67%. A quarter ago, it was expected that this company would post a loss of $0.23 per share when it actually produced a loss of $0.25, delivering a surprise of -8.70%. Sera Prognostics, Inc. (SERA) came out with a quarterly loss of $0.20 per share versus the Zacks Consensus Estimate of a loss of $0.24. This compares to loss of $0.25 per share a year ago. These figures are adjusted for non-recurring items. There are no easy answers to this key questi ...

Core Viewpoint - Century Aluminum reported quarterly earnings of $0.28 per share, missing the Zacks Consensus Estimate of $0.53 per share, representing a 47.17% earnings surprise [1] - The company posted revenues of $633.9 million for the quarter, missing the Zacks Consensus Estimate by 1.54%, but showing an increase from $489.5 million year-over-year [2] Financial Performance - The earnings report indicates a loss of $0.39 per share in the same quarter last year, highlighting a significant improvement in earnings [1] - Over the last four quarters, Century has surpassed consensus EPS estimates two times and topped revenue estimates twice [2] Stock Performance - Century shares have declined approximately 9.7% since the beginning of the year, compared to a 4.7% decline in the S&P 500 [3] - The current Zacks Rank for Century is 5 (Strong Sell), indicating expectations of underperformance in the near future [6] Future Outlook - The consensus EPS estimate for the upcoming quarter is $0.97 on revenues of $660.1 million, and for the current fiscal year, it is $3.36 on revenues of $2.48 billion [7] - The Metal Products - Procurement and Fabrication industry is currently in the top 31% of Zacks industries, suggesting a favorable industry outlook [8]

Financial Performance - Alta Equipment reported a quarterly loss of $0.65 per share, which was worse than the Zacks Consensus Estimate of a loss of $0.60, and compared to a loss of $0.38 per share a year ago, indicating a decline in performance [1] - The company posted revenues of $423 million for the quarter ended March 2025, missing the Zacks Consensus Estimate by 3.11%, and down from $441.6 million in the same quarter last year [2] - Over the last four quarters, Alta Equipment has not surpassed consensus EPS estimates and has topped consensus revenue estimates only once [2] Stock Performance - Since the beginning of the year, Alta Equipment shares have lost approximately 27.1%, significantly underperforming the S&P 500, which declined by 4.7% [3] - The current Zacks Rank for Alta Equipment is 3 (Hold), indicating that the shares are expected to perform in line with the market in the near future [6] Earnings Outlook - The current consensus EPS estimate for the upcoming quarter is -$0.30 on revenues of $482.42 million, and for the current fiscal year, it is -$1.39 on revenues of $1.89 billion [7] - The trend of estimate revisions for Alta Equipment is mixed, and future changes in estimates will be closely monitored following the recent earnings report [6][7] Industry Context - The Manufacturing - General Industrial industry, to which Alta Equipment belongs, is currently ranked in the bottom 37% of over 250 Zacks industries, suggesting a challenging environment for the sector [8]

LegalZoom (LZ) came out with quarterly earnings of $0.13 per share, in line with the Zacks Consensus Estimate. This compares to earnings of $0.09 per share a year ago. These figures are adjusted for non-recurring items. A quarter ago, it was expected that this online platform for legal services would post earnings of $0.16 per share when it actually produced earnings of $0.19, delivering a surprise of 18.75%. Over the last four quarters, the company has surpassed consensus EPS estimates three times. LegalZo ...

Company Performance - Hamilton Insurance reported quarterly earnings of $0.47 per share, significantly exceeding the Zacks Consensus Estimate of $0.04 per share, but down from $1.38 per share a year ago, representing an earnings surprise of 1,075% [1] - The company posted revenues of $768.78 million for the quarter ended March 2025, surpassing the Zacks Consensus Estimate by 31.08%, compared to $658.65 million in the same quarter last year [2] - Over the last four quarters, Hamilton Insurance has surpassed consensus EPS estimates three times and topped consensus revenue estimates two times [2] Stock Outlook - The immediate price movement of Hamilton Insurance's stock will depend on management's commentary during the earnings call and future earnings expectations [3][4] - The current consensus EPS estimate for the upcoming quarter is $1.01 on revenues of $617.28 million, and for the current fiscal year, it is $2.66 on revenues of $2.48 billion [7] - The stock currently holds a Zacks Rank 3 (Hold), indicating it is expected to perform in line with the market in the near future [6] Industry Context - The Insurance - Multi line industry, to which Hamilton Insurance belongs, is currently ranked in the top 31% of over 250 Zacks industries, suggesting a favorable outlook compared to the bottom 50% [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which can be tracked by investors [5]

Emergent Biosolutions (EBS) came out with quarterly earnings of $0.71 per share, beating the Zacks Consensus Estimate of $0.49 per share. This compares to earnings of $0.59 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 44.90%. A quarter ago, it was expected that this biopharmaceutical company would post a loss of $0.35 per share when it actually produced earnings of $0.05, delivering a surprise of 114.29%.Over the last four ...